NSE · AAREYDRUGS
Aarey Drugs & Pharmaceuticals Limited (AAREYDRUGS) Share Price
Historical price visualisation is temporarily undergoing corporate data-licensing maintenance. Full interactive price and chart data will return following our upcoming authorized NSE/BSE data-feed deployment. Derived metrics (valuation ratios, market-cap rank), company financials, shareholding, corporate actions, and mutual-fund holdings remain available.
Market cap rank
#2,119
of 5,047 stocks
🏆 New peak
▲ 831W▲ 601M
Peak #2,119 · 17 Nov 2026
A microcap name in Healthcare, Aarey Drugs & Pharmaceuticals Limited carries a steep earnings multiple that prices in strong future growth, has a subdued return on equity, and is seeing revenue slip.
Market Cap
355.30 Cr
P/E Ratio
79.94
P/B Ratio
2.10
ROE
2.64%
ROCE
6.84%
Dividend Yield
—
52W High
—
52W Low
—
Quarterly financials
| Metric | Q2 2026-27 | Q1 2026-27 | Q4 2025-26 | Q3 2025-26 |
|---|---|---|---|---|
| Revenue | 88.62 Cr | 44.63 Cr | 189.47 Cr | 96.43 Cr |
| Net Profit | 1.37 Cr | 1.02 Cr | 1.56 Cr | 56.95 L |
| EPS | 0.43 | 0.36 | 0.55 | 0.20 |
| Operating Profit | 2.82 Cr | 2.19 Cr | 3.06 Cr | 1.84 Cr |
Shareholding pattern
Promoter
37.71%
Public
62.29%
PUBLIC BREAKDOWN
FII
4.41%
DII
1.49%
Individuals
38.59%
Mutual fund holdings
Mutual fund holdings data for this stock hasn't been ingested yet — check back soon.
Recent corporate actions
| Ex-Date | Type | Details |
|---|---|---|
| 23 Sep 2024 | Other | Annual General Meeting |
| 29 Aug 2023 | Other | Annual General Meeting |
| 22 Sep 2022 | Other | Annual General Meeting |
| 02 Sep 2021 | Other | Annual General Meeting |
Other Healthcare stocks
Need this data in your app?
Full price history, technical indicators, and every field above via one REST API call.